Wolff-Parkinson-White syndrome (WPW), first descibed in 19301, is characterized by a short PR interval and a wide QRS complex with delta wave corresponding to ventricular pre-excitation. It is often asymptomatic although in a small percentage of cases may cause significant morbidity and occasionally mortality2'3.
WPW in infants has been described and appears to differ in prognosis4'5 and perhaps aetiology2'6 from its occurrence in later life. Although reports have been published of anaesthesia in patients with WPW7-16, to our knowledge none have been in patients less than three years of age. WPW may often present in infancy and the perioperative management and prognosis of such infants is discussed.
Presentation and anatomy of WPW WPW syndrome is a condition associated with ventricular pre-excitation and episodes of supraventricular tachycardia (SVT) or atrial fibrillation (AF)17. Two potential pathways of atrioventricular (AV) conduction are present, namely the normal pathway (atria-AV node-bundle of His-bundle branchventricle), and an accessory pathway. Since both the normal and the accessory pathway can operate in either A-V (antegrade) or V-A (retrograde) direction, the combination can form the substrate for a re-entrant or 'circus movement' tachycardia. AF is an additional hazard because the fast conduction properties of the accessory pathways can allow a very fast ventricular rate to develop as the normal delay of the AV node is bypassed.
In sinus rhythm, the presence of WPW pattern is recognized on the electrocardiogram (ECG) by a short PR interval and a wide QRS complex with a delta wave corresponding to ventricular pre-excitation.
Typically during a tachycardia, impulse conduction is antegrade along the normal pathway, and retrograde along the accessory pathway, so that there is a narrow QRS complex and the WPW pattern is not evident. In some instances, however, conduction of atrial impulses occur antegrade along the accessory pathway appearing as a wide QRS SVT on the ECG.
The prevalence of WPW in infants and children is between 0.4 and 1.0 per 10004, and is a common cause of paroxysmal SVT in the neonate6. In the absence of cardiac dysrhythmias the mild dyskinetic ventricular contractions accompanying this abnormality cause no clinical difficulties4. Although often asymptomatic, 50% or more will manifest a SVT at some stage4, and this may lead to congestive heart failure, syncope, chest pain18 or ventricular fibrillation'9. Most cases will present at under two years, with up to 60% at less than two months5'20. Of patients with WPW a small percentage present with an abrupt transition from a benign to a life threatening course19, and sudden death has been reported in an otherwise healthy child21. It is therefore prudent to assume that a benign past does not imply a benign future, and every patient with the syndrome must be treated accordingly.
WPW in children
Although the mechanism is the same in children and adults, the electrophysiology2 and the natural history differ45. Muscular bridges between atria and ventricles may be found in normal foetal and newborn heart, although they are rare in older children6. The prevalence of WPW in young infants may be secondary to this anatomic incompleteness possibly coupled with excessive cholinergic influences predominating in this age group6. In children WPW is sometimes associated with congenital heart disease, most commonly Ebstein's anomaly, although other associated defects have been described45"9. Unlike adults, the natural history in children is for the condition to improve during the first year of life4'5"19. This may be due to the absorption of aberrant AV connections, the maturation of the conduction system, or the bypass fibres becoming electrically quiescent. However of SVT is common, hence the frequent need to place these babies on prophylactic therapy during this period. Digoxin has been widely used with good effect. Occasionally propranolol, quinidine, or amiodarone must be added.
Treatment of SVT
The condition commonly first presents with a SVT which typically has a narrow QRS complex, difficult to distinguish from other forms of atrial tachycardia. Whatever the mechanism, suppression of the SVT is the main objective in acute management. Figure 1 outlines treatment and Table 1 shows relevant dosages.
Vagal stimulation prolongs AV nodal conduction and refractoriness. A surge of vagal stimuli can be triggered by the 'diving reflex' (cold water to the face) or by carotid sinus massage. Drugs that suppress conduction in one or both limbs ofthe re-entrant circuit are also effective. Digoxin given intravenously is the initial drug used for narrow complex tachycardias, exerting its effect through its action on the vagus. Reportedly, it converts SVT to sinus rhythm in 87% ofcases ofWPW22. Propranolol has been used in WPW syndrome unresponsive to digitalis. Its disadvantages are myocardial depression and a severe bradycardia that can occur if combined with digoxin. Occasional resistant cases of paroxysmal SVT may require overdrive atrial pacing or parenteral amiodarone to suppress the arrhythmia. In older children, verapamil has been used to manage the paroxysmal SVT as it prolongs AV nodal conduction, but its negative inotropic effect is a concern in the neonate23. Wide complex SVT and AF with rapid ventricular rate are poorly tolerated and best managed by direct current cardioversion followed by digoxin administration to prevent recurrence22. In older children with wide QRS SVT, or AF and fast ventricular response, digoxin is contraindicated as it can increase the tachycardia by shortening the refractory period ofthe accessory pathway2425. Tachyarrhythmias, severe heart failure, and even hydrops foetalis may occur in foetuses with WPW syndrome26-28, occasionally leading to intrauterine death. Treatment may be commenced prior to delivery with digoxin administered to the mother. Digoxin may not always be appropriate but if so, will be effective as foetal and maternal plasma levels are similar26. Resistant cases may improve with the addition of propranolol27.
Anaesthesia and WPW Anaesthesia in these patients is potentially hazardous, and may theoretically trigger attacks of SVT by producing sinus tachycardia or ventricular ectopics. These may be poorly tolerated if inhalational agents with a depressant effect on the myocardium are used.
The syndrome may be recognized for the first time during anaesthesia'2, presenting a diagnostic dilemma8. It has been suggested that the aim of anaesthetic management should be the avoidance of tachyarrhythmias and sympathetic stimulation7'9"4. For this reason premedication with atropine is not recommended13. Although caution with thiopentone has been advised, it has been used in modest dosage without problem9. A variety of techniques have been advocated for maintenance. These include nitrous oxide/narcotic, neurolept, and deep inhalational anaesthesia9"10"12-'4. Of the inhalational agents, isoflurane has the advantage of causing least myocardial depression. Vecuronium may be the muscle relaxant of choice and spontaneous recovery from non depolarizing neuromuscular blockade avoids the possible dangers of reversal agents7. Maintenance of good acid base balance and body temperature will minimize attacks of PSVT. WPW may therefore manifest in early life, be life threatening and difflcult to treat. Our experience illustrates several aspects ofWPW, and demonstrates one approach to the anaesthetic management.
Case report
The patient was the third child ofa 36-year-old woman. Ultrasound during pregnancy showed hydramnios, foetal ascites and hydrocephalus. Foetal heart monitoring indicated intermittent SVT. Prior to delivery the mother was given digoxin (0.25 mg twice a day for three days) and a caesarian section at 33 weeks gestation was carried out under epidural anaesthesia. The male infant weighed 2.7 kg at birth but after drainage of the ascitic fluid this decreased to 2.2 kg. He was electively intubated and ventilated for 10 days. Cardiac echo showed normal anatomy and function, with a suggestion of left ventricular hypertrophy. The ECG confirmed a diagnosis of WPW syndrome.
His first post delivery episode of SVT was at 9 hours and responded to verapamil. He had further episodes, and various drugs were tried with variable effect including verapamil, digoxin, flecainide and amiodarone. Rapid oesophageal pacing was used with some success. The most reliable treatment was immersion ofhis face in cold water for 5 to 10 seconds. The ascites was thought to be due to cardiac failure in utero secondary to recurrent SVT. Abnormal liver function tests also developed from the day after delivery. He presented 13 weeks post delivery for insertion of a parieto-occipital ventriculo-peritoneal shunt. At this time he had been off all medication for three weeks and the episodes of SVT were treated with cold water immersion as necessary.
Prior to anaesthesia, in addition to our standard preparations, ice cold sterile saline and amiodarone were available in theatres. Vitamin K was given preoperatively but atropine, our routine premedication, was omitted. On arrival in the anaesthetic room the patient was kept warm, an ECG was monitored and intravenous access obtained. After preoxygenation, anaesthesia was induced with thiopentone. Atracurium was administered and the child hand ventilated with a T piece circuit on a 50: 50 mixture of nitrous oxide (N20) and oxygen (02). After intubation isoflurane was added as indicated and mechanical ventilation instituted. The child was wrapped in foil and placed on a hot air mattress. Monitoring consisted of Dinamap, ECG, pre-cordial stethoscope, rectal temperature probe and pulse oximeter. At the end of surgery 100%°2 was given, muscle power was allowed to recover spontaneously and, when the child was awake and attempting to cry, the endotracheal tube was removed. The child was then transferred to an incubator. Monitoring of 02 saturation and ECG continued on the ward.
Throughout surgery his heart rate was stable between 130 and 180 beats per minute. The day after operation he had several runs of SVT aborted with difflculty using vagal stimulation. He later experienced brief episodes of transient bradycardia including one reportedly to a rate of 40. The spells of SVT continued and after one prolonged episode which did not respond to vagal stimulation, intravenous propranolol proved effective and oral prophylaxis was commenced.
Three months later he was readmitted with a blocked shunt. During this period he had been discharged home, was not taking medication for the WPW, and had no clinical evidence of episodes of tachycardia. Prior to surgery he experienced two episodes of SVT. One of these was unresponsive to vagal stimulation but terminated after 25 min, 10 min after verapamil was administered and coincidental with the removal of cerebrospinal fluid. The operation was uneventful with an identical technique to his first anaesthetic. In the 5 days after the operation he had 5 short-lived SVT's, all aborted by cold water immersion. Two weeks later his bilateral hydroceles were repaired under a further uneventful anaesthetic with the same agents. One further uneventful anaesthetic was given shortly afterwards for a CT scan. Premedication was with atropine, but otherwise management was as before. No further episodes of SVT occurred and he was discharged shortly after.
Conclusion
In conclusion, the problem of WPW adds one further hazard to those inherent in anaesthesia for the newborn. WPW often manifests as a SVT in infants and must be treated accordingly. With increasing age the condition commonly improves.
